Physician profile
Gaurav Abbi
NPI 1700074853
$3,656.12
in general payments reported to CMS, 2019-2025
20 companies · $1,303 in 2025
The $1,303 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $537 · 2020: $757 · 2021: $49.23 · 2022: $460 · 2023: $234 · 2024: $316 · 2025: $1,303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $768 · Travel and Lodging: $730 · Education: $356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $768.36 |
| Travel and Lodging | $729.58 |
| Education | $355.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,405.35 | 2019-2025 | Rosa, Persona, Osseofit |
| Spineology INC. | $823.61 | 2020-2022 | |
| Stryker Corporation | $300.02 | 2020-2025 | Gamma, Aequalis Ascend Flex, Mako |
| Medical Device Business Services, INC. | $289.10 | 2019-2025 | Ethicon |
| Medtronic, INC. | $149.66 | 2022 | |
| Gilead Sciences, INC. | $109.58 | 2019 | |
| Providence Medical Technology, INC. | $106.28 | 2025 | |
| Microport Orthopedics INC | $83.05 | 2019 | |
| Surgalign Spine Technologies, INC. | $77.40 | 2019 | |
| Si-Bone, INC. | $66.99 | 2024 | |
| Smith+Nephew, INC. | $49.81 | 2020 | |
| Globus Medical, INC. | $43.47 | 2023 | Excelsiusgps Robotic Navigation System |
| Orthofix Medical, INC. | $24.80 | 2024-2025 | Physio-Stim |
| Moximed, INC | $24.26 | 2025 | Misha Knee System, Small, Left |
| Depuy Synthes Sales INC. | $21.59 | 2025 | Monovisc |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $19.47 | 2025 | Eterna |
| Sanara Medtech INC. | $17.78 | 2024 | Celleraterx |
| Bioventus LLC | $17.19 | 2023 | Gelsyn-3 |
| Nevro Corp. | $13.48 | 2020 | |
| Merck Sharp & Dohme LLC | $13.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gaurav Abbi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.